Companies: 10,795·Total market cap: $144.5T
Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDACNASDAQFinancial Services● Active
$10.76
+$0.02(+0.19%)
Market Cap$235724689
P/E Ratio
52W High$10.8
52W Low$10.21
Overview

Translational Development Acquisition Corp. (TDAC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TDAC · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.29tdac eps ttm · tdac earnings per shareEarnings history
PE Ratio (TTM)37.4×tdac pe ratio ttm · tdac price to earningsPE Ratio deep dive
Revenue (TTM)0.00tdac revenue ttm · tdac annual revenueFull revenue history
Dividend YieldNo Dividenddoes tdac pay dividends · tdac dividend yieldDividend history
Shares Outstanding17.3Mtdac shares outstanding · tdac floatShares outstanding history
Next EarningsTBAtdac earnings date · tdac next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
translational development acquisition corp. revenue · tdac revenue 2025
FY 2025Net Income$6.4M▲ +9059.65% YoY
202320242025
translational development acquisition corp. net income · tdac profit 2025
FY 2025EPS$0.37▲ +2383.95% YoY
202320242025
tdac eps · translational development acquisition corp. earnings per share 2025
TTM:Revenue: $0.00Net Income: $6.2MEPS: $0.29View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis tdac a buy · tdac analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$10.76Current
$Avg Target
$High
tdac price target · tdac 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D+0.19%
1W+0.00%
1M+1.22%
3M+2.09%
YTD+2.57%
1Y+5.39%
5Y+7.49%

About Translational Development Acquisition Corp.

CEOMichael Hoffman
IPO DateFeb 20, 2025
Employees2
CountryUS

Translational Development Acquisition Corp. founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business …

what is translational development acquisition corp. · tdac stock overview · translational development acquisition corp. company profile · who is translational development acquisition corp. ceo · tdac NASDAQ · translational development acquisition corp. headquarters · translational development acquisition corp. business segments

About Stock Overview & Key Data

Translational Development Acquisition Corp. (TDAC) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Feb 20, 2025. As of the latest trading session, TDAC stock price is $10.76, with a market capitalization of $235.7M. The stock has returned +5.39% over the past 12 months and +2.57% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Translational Development Acquisition Corp. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Translational Development Acquisition Corp. reported revenue of — and net income of $6.4M. For detailed data — including Translational Development Acquisition Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Translational Development Acquisition Corp. (TDAC) stock price is $10.76. The stock is traded on NASDAQ under the ticker symbol TDAC. The 52-week range is $10.21 – $10.80.

TDAC stock priceTDAC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice